Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

551.38 -1.47 (-0.27%)
Streaming Delayed Price Updated: 10:16 AM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
News headline image
3 Supercharged Growth Stocks to Buy and Hold Into the 2030s ↗
Growth stocks fall in and out of favor with investors, but quality businesses are always worth buying. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Forget Moderna Stock, This is a Much Better Buy ↗
This stock is a great choice for cautious and aggressive investors. 
Via The Motley Fool
Topics Intellectual Property
News headline image
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
On December 23, 2025, the biotechnology landscape shifted for thousands of patients living with chronic anemia. The U.S. Food and Drug Administration (FDA) granted approval to AQVESME (mitapivat),... 
Via PredictStreet
Topics Economy
News headline image
Is CRISPR Therapeutics Stock Yesterday's News? ↗
The biotech sells blood disorders treatment, Casgevy. 
Via The Motley Fool
News headline image
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global... 
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
News headline image
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A GARP Case Study in Affordable Growth ↗
Vertex Pharmaceuticals (VRTX) exemplifies GARP investing, offering strong earnings growth, top profitability, and a debt-free balance sheet at a reasonable market valuation. 
Via Chartmill
News headline image
2 Cash-Producing Stocks to Consider Right Now and 1 We Find Risky
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗
Next year could be crucial for the company as sales for its only approved treatment could take off. 
Via The Motley Fool
News headline image
2 Reasons to Watch VRTX and 1 to Stay Cautious
Since June 2025, Vertex Pharmaceuticals has been in a holding pattern, posting a small return of 0.5% while floating around $450.68. The stock also fell short of the S&P 500’s 13.6% gain during that... 
Via StockStory
Topics Stocks
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
Issued on behalf of Avant Technologies Inc. 
From USA News Group
Via GlobeNewswire
News headline image
12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗
The following players span a variety of industries, so if you pick up more than one, you may gain in diversification. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Vertex Pharmaceuticals (NASDAQ:VRTX) Combines Strong Growth with Technical Breakout Potential ↗
Vertex Pharmaceuticals (VRTX) shows strong growth fundamentals and a positive technical breakout setup, combining high earnings forecasts with a promising stock chart pattern. 
Via Chartmill
News headline image
2 Healthcare Stocks to Buy Ahead of the New Year ↗
These companies could innovate their way to success. 
Via The Motley Fool
News headline image
Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth
As 2025 draws to a close, a powerful undercurrent of technological innovation, extending far beyond the pervasive influence of artificial intelligence, is demonstrably reshaping the global stock... 
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
News headline image
1 Large-Cap Stock to Consider Right Now and 2 Facing Challenges
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
News headline image
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? ↗
The stock has fallen from a peak back in April. 
Via The Motley Fool
News headline image
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
1 Reason I'll Never Sell Vertex Pharmaceuticals Stock ↗
The stock has climbed in the double-digits in recent years. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
News headline image
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
What's going on in today's session: S&P500 movers ↗
Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
News headline image
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
Both can help drive excellent returns for patient, disciplined investors. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Top Stocks to Buy in December ↗
These stocks deserve a spot on investors' shopping lists this holiday season. 
Via The Motley Fool
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
This company's first product has started to generate revenue. 
Via The Motley Fool
Topics ETFs
News headline image
Vertex (VRTX) Q3 2025 Earnings Call Transcript ↗
Vertex (VRTX) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Where Will Vertex Pharmaceuticals Be in 5 Years ↗
Prediction: Vertex will be much larger by the end of the decade. 
Via The Motley Fool
News headline image
2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon ↗
If you're investing for the next 30 years, don't overlook these top stocks. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why
Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 2.7% in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 
Via StockStory
Topics Artificial Intelligence Economy Supply Chain
News headline image
2 Inflation-Proof Growth Stocks That Could Outperform the Market ↗
Inflation should have a minimal impact on these companies' financial results. And they also boast excellent growth prospects. 
Via The Motley Fool
Topics Economy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.